Abstract
The practice of nuclear medicine leads to a potential risk of exposure for the patient. The activity of radiopharmaceutical should be administered in order to guarantee the correct balance between risks and benefits. In the last years, the introduction of technological advances, the increased availability of scanning equipment, and new radiopharmaceuticals lead to an intensified use of nuclear medicine examinations. On the one hand, these improvements involved in a remarkable progress in image quality; on the other hand, technological advances do not necessarily imply a decrease in patient exposure to ionizing radiation. The implementation of radiation protection practices aimed to limit radiation exposure in nuclear medicine exams is an utmost need. For pediatric patient, a more attention has to be paid as they have higher tissue radiosensitivity and longer life expectancy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Alessio AM, Farrell MB, Fahey FH. Role of reference levels in nuclear medicine: a report of the SNMMI dose optimization task force. J Nucl Med. 2015;56(12):1960–4.
Attix FH. Introduction to radiological physics and radiation dosimetry. New York: Wiley; 1986.
Bailey DL, Humm JL, Todd-Pokropek A, Van Aswegen A. Nuclear medicine physics: a handbook for teachers and students. Vienna: International Atomic Energy Agency; 2014.
Bolch WE, et al. MIRD pamphlet no. 17: the dosimetry of non-uniform activity distributions: radionuclide S values at the voxel level. J Nucl Med. 1999;40(Suppl):11S–36.
Council directive 97/43/EURATOM of 30 June 1997 on health protection of individuals against the dangers of ionising radiation in relation to medical exposure. Off J Eur Comm, No L 180.
European Commission. Radiation protection n. 109. Guidance on diagnostic reference levels (DRLs) for medical exposures. 1999.
European Commission. Radiation protection n. 180. Diagnostic reference levels in thirty-six European countries. 2014.
Fahey FH, Stabin M. Dose optimization in nuclear medicine. Semin Nucl Med. 2014;44:193–201.
Fahey FH, Treves ST, Adelstein SJ. Minimizing and communicating radiation risk in pediatric nuclear medicine. J Nucl Med. 2011;52(8):1240–51.
Health risks from exposure to low levels of ionizing radiation: BEIR VII Phase 2. 2006.
ICRP. The 2007 recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP. 2007;37(2–4):1–332.
ICRP. Radiation dose to patients from radiopharmaceuticals – addendum 3 to ICRP publication 53. ICRP publication 106. Ann ICRP. 2008;38(1–2):1–197.
ICRP. Radiological protection and safety in medicine. ICRP publication 73. Ann ICRP. 1996;26(2).
Johns HE, Cunningham JR. The physics of radiology. 4th ed. Springfield: Charles C. Thomas; 1983.
National Council on Radiation Protection and Measurements, Report No. 136. Evaluation of the linear-nonthreshold dose-response model for ionizing radiation. 2001.
Siegel JA, et al. MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med. 1999;40:37S–61.
Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Cannatà, V., Genovese, E., Longo, M. (2017). Radiation Risk. In: Garganese, M., D'Errico, G. (eds) Conventional Nuclear Medicine in Pediatrics. Springer, Cham. https://doi.org/10.1007/978-3-319-43181-9_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-43181-9_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43179-6
Online ISBN: 978-3-319-43181-9
eBook Packages: MedicineMedicine (R0)